Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Jan 19, 2026

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

Response to Grech et al.: FLOUX-PMS study sample considerations

Jop P Mostert¹, Jacques De Keyser^2,3,4

¹Department of Neurology, Rijnstate Hospital, Arnhem, The Netherlands.

Multiple Sclerosis (Houndmills, Basingstoke, England)

|September 21, 2019

Summary

No abstract available in PubMed .

Related Experiment Videos

Last Updated: Jan 19, 2026

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Prescriptions and healthcare use in multiple sclerosis patients within general practices in the Netherlands.

Multiple sclerosis and related disorders·2026

Same author

Evaluating the effect of cannabidiol on sleep quality in patients with multiple sclerosis using 15 aggregated N-of-1 trials: A study protocol.

Contemporary clinical trials·2025

Same author

Response to critical appraisal of patient selection methods in MS prevalence studies.

Multiple sclerosis and related disorders·2025

Same author

Prevalence and incidence of multiple sclerosis in the Netherlands.

Multiple sclerosis and related disorders·2024

Same author

Serum neurofilament light and glial fibrillary acidic protein levels are not associated with wearing-off symptoms in natalizumab-treated multiple sclerosis patients.

Multiple sclerosis (Houndmills, Basingstoke, England)·2024

Same author

Prospective trial of natalizumab personalised extended interval dosing by therapeutic drug monitoring in relapsing-remitting multiple sclerosis (NEXT-MS).

Journal of neurology, neurosurgery, and psychiatry·2023